ADVERTISEMENT
  • Campus
  • Happening
  • Opinion
  • People
  • News
  • #BeInspired
  • Careers
  • 40 under 40
  • Exams
  • What The FAQ
  • Videos
    • Straight Up
    • Odisha Literary Festival 2020
    • Campus Convo
    • Careers After Corona
    • Express Expressions
    • Q&A With Prabhu Chawla
    • ThinkEdu Awards 2020
ADVERTISEMENT
research

Published: 30th June 2020     

CCRS to begin study on prophylactic use of Siddha in treating COVID-19 cases

Similar study is on at the SCRI units at Bengaluru, Delhi, Tirupati, Palayamkottai and Puducherry.

Edex Live
Edex Live

Share Via Email

COVID-19

COVID-19

With a Siddha 'add-on' therapy to allopathic treatment at a government COVID-19 care centre here giving encouraging results, the Central Council for Research in Siddha (CCRS) will soon commence a study on 60 coronavirus patients at Vysarpadi in the city.

The new clinical trial aims to bring out the efficacy of the Siddha group of medicines and 'Kabasura kudineer' as prophylactic designed to treat or prevent COVID-19.

The add-on therapy was earlier attempted at the COVID-19 care centre at the Government Stanley Medical College Hospital.

Kabasura kudineer is a herbal concoction, comprising dry ingredients of ginger, pippali, clove, cirukancori root and many other herbs.

"We are awaiting the number from the Clinical Trials Registry-India (CTRI) to begin the trial next week," Dr K Kanakavalli, director general of CCRS, said.

CCRS is the apex body pertaining to research in Siddha system of medicine.

It works towards the scientific validation of Siddha system of medicine through clinical research, drug research, medicinal plants research, fundamental research, literary research and documentation.

The new study is in sync with the directive issued by the Union Ayush Ministry and with the consent from the Tamil Nadu government.

"About 60 asymptomatic, mild and moderate coronavirus positive patients would be taken up for study at the COVID-19 Care Centre established by Greater Chennai Corporation at Vysarpadi," she told PTI on Monday.

"Siddha, which was recently tried at Stanley GH as add-on therapy on 30 positive patients, proved successful and based on the outcome we have decided to take up the new study," she said.

Earlier, the Siddha Central Research Institute (SCRI) here conducted a prophylactic study on 15,000 mild or moderate coronavirus patients and those who were asymptomatic.

Similar study is on at the SCRI units at Bengaluru, Delhi, Tirupati, Palayamkottai and Puducherry. These studies are aimed at evaluating Kabasura kudineer as drug of choice. Recently, a retrospective study on the herbal concoction and group of Siddha medicines was conducted in Coimbatore.

telegram
TAGS
research Coronavirus COVID-19 CCRS Chennai
    Related Article
  • NIT Tiruchy Director responds to student protests: Senate has asked us to conduct exams, I can't do much
  • Our researchers need to innovate and lead, not finds gaps in others' theories and follow: Dr Uday B Desai
  • Why it is only people who are illiterate about viruses that will call the lockdown useless

O
P
E
N

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
telegram
ADVERTISEMENT
Write to us!

If you have campus news, views, works of art, photos or just want to reach out to us, just drop us a line.

Mailbox
edexlive@gmail.com
Facebook
Twitter
Instagram
ADVERTISEMENT
Facebook
ADVERTISEMENT
Tweets by Xpress_edex
ADVERTISEMENT
ADVERTISEMENT

FOLLOW US

Copyright - edexlive.com 2021

The New Indian Express | Dinamani | Kannada Prabha | Samakalika Malayalam | Indulgexpress | Cinema Express | Event Xpress

Contact Us | About Us | Privacy Policy | Terms of Use | Advertise With Us

Home | Live Now | Live Story | Campus Trip | Coach Calling | Live Take